全文获取类型
收费全文 | 22842篇 |
免费 | 2302篇 |
国内免费 | 768篇 |
专业分类
耳鼻咽喉 | 170篇 |
儿科学 | 259篇 |
妇产科学 | 206篇 |
基础医学 | 920篇 |
口腔科学 | 645篇 |
临床医学 | 3741篇 |
内科学 | 1705篇 |
皮肤病学 | 161篇 |
神经病学 | 790篇 |
特种医学 | 584篇 |
外国民族医学 | 7篇 |
外科学 | 1366篇 |
综合类 | 3357篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 5728篇 |
眼科学 | 107篇 |
药学 | 3354篇 |
80篇 | |
中国医学 | 2136篇 |
肿瘤学 | 594篇 |
出版年
2024年 | 179篇 |
2023年 | 591篇 |
2022年 | 980篇 |
2021年 | 1141篇 |
2020年 | 1209篇 |
2019年 | 946篇 |
2018年 | 881篇 |
2017年 | 932篇 |
2016年 | 998篇 |
2015年 | 957篇 |
2014年 | 1765篇 |
2013年 | 1918篇 |
2012年 | 1581篇 |
2011年 | 1611篇 |
2010年 | 1237篇 |
2009年 | 1159篇 |
2008年 | 1072篇 |
2007年 | 1030篇 |
2006年 | 906篇 |
2005年 | 711篇 |
2004年 | 614篇 |
2003年 | 523篇 |
2002年 | 401篇 |
2001年 | 361篇 |
2000年 | 299篇 |
1999年 | 290篇 |
1998年 | 237篇 |
1997年 | 183篇 |
1996年 | 167篇 |
1995年 | 132篇 |
1994年 | 134篇 |
1993年 | 98篇 |
1992年 | 102篇 |
1991年 | 81篇 |
1990年 | 68篇 |
1989年 | 58篇 |
1988年 | 54篇 |
1987年 | 36篇 |
1986年 | 45篇 |
1985年 | 49篇 |
1984年 | 42篇 |
1983年 | 18篇 |
1982年 | 19篇 |
1981年 | 19篇 |
1980年 | 27篇 |
1979年 | 8篇 |
1978年 | 16篇 |
1977年 | 11篇 |
1975年 | 7篇 |
1974年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
目的 建立一测多评(quantitative analysis of multicomponents by single-marker,QAMS)法同时检测盐沙苑子饮片中杨梅素、扁蓄苷、杨梅素-3-O-β-D-葡萄糖苷、毛蕊异黄酮葡萄糖苷、西伯利亚落叶松黄酮、沙苑子苷B、沙苑子苷A、毛蕊异黄酮、芒柄花素、鼠李柠檬素、豆甾醇、胡萝卜苷、β-谷甾醇含量的方法,并采用主成分分析法(principal component analysis,PCA)、正交偏最小二乘法-判别分析(orthogonal partial least squares-discriminant analysis,OPLS-DA)法及熵权逼近理想解排序(entropy weight-technique for order preference by similarity to ideal solution,EW-TOPSIS)法对其质量进行评价。方法 采用Lichrospher C18色谱柱;乙腈-0.2%磷酸水溶液为流动相梯度洗脱。以沙苑子苷A为内参物,建立内参物与其他12个待测成分的相对校正因子(relative co... 相似文献
112.
中药质量评价作为保障中药材及饮片质量安全有效的有力手段,对维护人民群众身心健康、促进中药产业高质量发展具有重要意义。长久以来,中药质量多以法定检验标准为准入门槛进行低限控制,质量等级标准缺乏,致使中药质量仅能满足基本要求,而“优质优价”未能得到充分体现,导致“劣币驱逐良币”,市场公平严重受损,这很大程度影响了中药产业高质量发展。因此,开展中药质量优劣评价研究,构建中药质量等级标准体系对于全面落实“四个最严”要求、促进中医药传承创新发展、规范市场秩序、引导产业健康发展具有深远而重大的意义。对中药材质量评价现状进行概述,针对目前中药材质量评价的瓶颈问题,提出符合中医药特点的质量等级标准研究思路,包括关键质量控制指标确立、综合质量评价方法建立、质量等级标准验证等内容,以期为建立中药质量等级评价体系提供参考,助力中药产业高质量发展。 相似文献
113.
Jessica K. Salwen-Deremer Jennifer M. Lauretti Kelly A. Aschbrenner Leslie Heinberg Stephen J. Ritz Stephanie Sogg 《Surgery for obesity and related diseases》2021,17(6):1182-1189
BackgroundA psychosocial evaluation is an important component of the preoperative assessment process for people seeking metabolic and bariatric surgery (MBS), and is required for accreditation of MBS programs. Recently, independent companies without affiliations with MBS programs have been marketing remotely administered, unaffiliated psychosocial evaluations for MBS (RUS), and American Society for Metabolic and Bariatric Surgery (ASMBS) members have raised concerns about these evaluations.ObjectivesTo explore ASMBS members’ beliefs about RUS.SettingOnline survey.MethodsWe developed a survey to evaluate ASMBS members’ opinions, experiences, and/or concerns about in-person and RUS psychosocial evaluations for MBS.ResultsIn total, 635 ASMBS members responded to the online survey and 156 responded to an open-ended question on RUS. Responses were coded based on a manual developed for this study, yielding themes of concerns about the quality of RUS, lack of ongoing relationships in RUS, and conditions under which/reasons why RUS evaluations could be acceptable.ConclusionRespondents expressed both interest in and concerns about RUS in pre-MBS psychosocial evaluations. Use of RUS has the potential to improve access to MBS by providing a convenient and efficient means of completing the psychosocial evaluation. Conversely, respondents expressed concerns about the background and training of RUS providers, the quality of the reports, and the limited relationships between the RUS provider and both the MBS patient and the MBS team. We discuss the clinical and research implications of response themes, particularly for patients in rural areas or those who have other barriers to care. 相似文献
114.
Stefan Schwarz Nina Rahimi Daria Kifjak Moritz Muckenhuber Martin Watzenböck Alberto Benazzo Peter Jaksch Sylvia Knapp Walter Klepetko Konrad Hoetzenecker the Vienna Lung Transplant Group 《American journal of transplantation》2021,21(6):2132-2144
Objectifying donor lung quality is difficult and currently there is no consensus. Several donor scoring systems have been proposed in recent years. They all lack large-scale external validation and widespread acceptance. A retrospective evaluation of 2201 donor lungs offered to the lung transplant program at the Medical University of Vienna between January 2010 and June 2018 was performed. Five different lung donor scores were calculated for each offer (Oto, ET, MALT, UMN-DLQI, and ODSS). Prediction of organ utilization, 1-year graft survival, and long-term outcome were analyzed for each score. 1049 organs were rejected at the initial offer (group I), 209 lungs declined after procurement (group II), and 841 lungs accepted and transplanted (group III). The Oto score was superior in predicting acceptance of the initial offer (AUC: 0.795; CI: 0.776–0.815) and actual donor utilization (AUC: 0.660; CI: 0.618–0.701). Prediction of 1-year graft survival was best using the MALT score, Oto score, and UMN-DLQI. Stratification of early outcome by MALT was significant for length of mechanical ventilation (LMV), PGD3 rates, ICU stay and hospital stay, and in-hospital-mortality, respectively. To the best of our knowledge, this study is the largest validation analysis comparing currently available donor scores. The Oto score was superior in predicting organ utilization, and MALT score and UMN-DLQI for predicting outcome after lung transplantation. 相似文献
115.
116.
117.
Cate Bailey Helen Skouteris Heather Morris Renee O’Donnell Briony Hill Zanfina Ademi 《Health & social care in the community》2021,29(6):1650-1667
Home-visiting interventions are used to improve outcomes for families experiencing disadvantage. As scarce resources must be allocated carefully, appropriate methods are required to provide accurate information on the effect of these programmes. We aimed to investigate: economic evaluation/analysis methods used in home-visiting programmes for children, young people and families, study designs and methods suitable in situations where randomised-controlled-trials are not feasible, and type of costs included in analyses, including any implementation costs stated. A systematic search and review was conducted of existing full economic evaluation/analysis methods in home-visiting programmes for children, young people and/or families. We included studies published in English between January 2000 and mid-November 2020. Of the 4,742 papers sourced, 60 were retained for full-text review, and 21 included. Economic-analysis methods found in the included studies were: within trial economic evaluation, economic evaluation using decision analytic modelling (i.e. cost-utility, cost-benefit analysis), cost comparison and cost-consequence. Studies incorporating return on investment and budget impact analysis were also found. Study designs suitable when randomisation was not feasible included parallel cluster randomised trials and using pre-post intervention data. Costs depended mainly on study context and only one study reported implementation costs. We hope this information will help guide future economic evaluations of home-visiting interventions. 相似文献
118.
119.
目的评价并遴选深圳市某区临床重点专科,为该区临床重点专科的发展以及我国临床重点专科的评估提供借鉴。方法将DRG相关指标与传统指标相结合作为该区临床重点专科评估指标体系,运用TOPSIS法计算该区11家医院41个临床专科2016—2018年的总排名。结果该区排名前5位的临床重点专科分别是I医院显微外科、J医院产科、K医院鼻科、K医院耳鼻咽喉科以及D医院骨科,排名后5位的专科分别是H医院风湿病科、D医院泌尿外科、C医院儿科、C医院眼耳鼻喉科以及F医院神经外科。结论该区应加快重点专科发展,形成区域专科优势;促进专科均衡发展,满足基本医疗需求;提高专科服务效率,优化医疗资源配置;依托医疗集团做强专科特色品牌,促进专科差异化发展;进一步提高病历首页质量管理水平。 相似文献
120.
《Vaccine》2022,40(37):5513-5522
BackgroundThe most common preventative measure against mumps is vaccination with mumps vaccine. Over 122 countries have implemented mumps vaccine routine immunization programs, mostly via Measles-Mumps-Rubella (MMR) vaccine. In Japan, the unexpectedly high incidence of aseptic meningitis caused by mumps vaccine led to the discontinuation of the MMR national vaccination program in 1993, inadvertently resulting in the re-emergence of mumps. Plans of introducing monovalent mumps vaccine into routine vaccination schedule have become one of the emerging topics in health policy that has warranted the need in evaluating its value for money.MethodsWe conducted cost-effectiveness analyses with Markov model and calculated incremental cost-effectiveness ratios (ICERs) of two different vaccination programs (a single-dose program at one-year-old, a two-dose program with second dose uptakes at five) compared to status quo from both payers’ and societal perspectives. Transition probabilities and utility weights in estimating quality-adjusted life-year (QALY), and disease treatment costs were either estimated or obtained from literature. Costs per vaccination were assumed at ¥6140 (US$58;1US$ = ¥106).ResultsBoth programs reduce disease treatment costs compared to status quo, while the reduction cannot offset vaccination cost. ICER of either program is found to be under ¥5,000,000 (US$47,170)/QALY willingness-to-pay (WTP) threshold from either perspective. Results of probabilistic sensitivity analyses expressed by net monetary benefit indicated that at the WTP threshold, the acceptability is at 92.6% for two-dose vaccination program, 0% for single-dose vaccination program, and 7.4% for current no vaccination program. Two-dose program was optimal among the alternatives. One-way sensitivity analyses revealed that proportion of mumps-related hearing loss among mumps cases and vaccine effectiveness (VE) were key variables in changing the ICERs.ConclusionRoutine vaccination program of single- and two-dose programs were cost-effective from both payers’ and societal perspectives. Between the two, the two-dose vaccination program was observed to be more favorable. 相似文献